Organigram Global (OGI) Exchange Rate Effect (2019 - 2026)
Organigram Global (OGI) posted quarterly Exchange Rate Effect of $294.6 million for Q1 2026, up 956.79% year-on-year from $27.9 million in Q1 2025, and up 65727.47% on a QoQ basis from -$448896.0 in Q4 2025.
Organigram Global (OGI) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Exchange Rate Effect for 5 consecutive years, with $294.6 million the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect rose 956.79% year-over-year to $294.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $323.5 million (up 913.01% YoY) and the FY2025 annual result came in at $227436.8, changed N/A from the prior year.
- Exchange Rate Effect climbed to $294.6 million in Q1 2026 per OGI's latest filing, from -$448896.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for OGI reached as high as $294.6 million in Q1 2026 and fell as low as -$448896.0 in Q4 2025.
- A 3-year average of $80.9 million and a median of $14.7 million in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect plunged 131.14% — and 2026, when it jumped 956.79%.
- Year by year, Exchange Rate Effect stood at $1.4 million in 2024, then tumbled by 131.14% to -$448896.0 in 2025, then surged by 65727.47% to $294.6 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $294.6 million, -$448896.0, and $27.9 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 294.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294.60 Mn |
| Mar 31, 2026 | 294.60 Mn |
| Dec 31, 2025 | -448,896.01 |
| Dec 31, 2025 | -448,896.01 |
| Mar 31, 2025 | 27.88 Mn |
| Mar 31, 2025 | 27.88 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Nov 30, 2020 | 71,000.00 |
| Nov 30, 2020 | 71,000.00 |
| May 31, 2020 | 2.54 Mn |
| May 31, 2020 | 2.54 Mn |
| Aug 31, 2019 | 26.00 |
| Aug 31, 2019 | 26.00 |
| May 31, 2019 | 25.92 Mn |
| May 31, 2019 | 25.92 Mn |